Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands

Filippo Minutolo, Simone Bertini, Adriano Martinelli, Gabriella Ortore, Giorgio Placanica, Giovanni Prota, Simona Rapposelli, Tiziano Tuccinardi, Shubin Sheng, Kathryn E. Carlson, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Marco Macchia

Research output: Contribution to journalArticle

Abstract

Estrogens play a crucial role in the development and function of female reproductive tissues. They have positive effects on the maintenance of bone mineral density, on the liver, and on the cardiovascular and central nervous systems. Selective Estrogen Receptor Modulators (SERMs) are particularly attractive as therapeutic agents because they are able to block estrogen action at those sites where stimulation would be undesirable, such as the breast and uterus, but at the same time stimulate estrogen actions in other tissues where they are desired, such as the bone and liver. Most synthetic estrogen receptor ligands possess a phenolic ring, mimicking the phenolic "Aring" of the natural ligand estradiol. In an attempt to increase the structural diversity of estrogen receptor (ER) ligands, we designed and synthesized molecules containing unprecedented replacements of the prototypical phenolic "A-ring" of estrogens with an oxime and a hydroxy- (salicylaldoximes) or aminomoieties (anthranylaldoximes), forming intramolecularly H-bonded pseudocycles. These new classes of compounds showed interesting ER binding properties on both receptor subtypes (ERα and ERβ). These results proved that the six-membered ring formed by an intramolecular hydrogen bond, and containing an exocyclic oxime OH, is an effective stereoelectronic replacement of the phenolic ring of typical ER ligands.

Original languageEnglish (US)
Pages (from-to)83-94
Number of pages12
JournalArkivoc
Volume2006
Issue number8
StatePublished - Jun 24 2006

Fingerprint

Phenol
Estrogen Receptors
Ligands
Estrogens
Oximes
Liver
Bone
Tissue
Estradiol Congeners
Selective Estrogen Receptor Modulators
Neurology
Minerals
salicylaldoxime
Estradiol
Hydrogen bonds
Molecules

Keywords

  • Binding
  • Estrogen
  • Ligands
  • Nuclear receptors
  • Oximes

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Minutolo, F., Bertini, S., Martinelli, A., Ortore, G., Placanica, G., Prota, G., ... Macchia, M. (2006). Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands. Arkivoc, 2006(8), 83-94.

Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands. / Minutolo, Filippo; Bertini, Simone; Martinelli, Adriano; Ortore, Gabriella; Placanica, Giorgio; Prota, Giovanni; Rapposelli, Simona; Tuccinardi, Tiziano; Sheng, Shubin; Carlson, Kathryn E.; Katzenellenbogen, Benita S.; Katzenellenbogen, John A.; Macchia, Marco.

In: Arkivoc, Vol. 2006, No. 8, 24.06.2006, p. 83-94.

Research output: Contribution to journalArticle

Minutolo, F, Bertini, S, Martinelli, A, Ortore, G, Placanica, G, Prota, G, Rapposelli, S, Tuccinardi, T, Sheng, S, Carlson, KE, Katzenellenbogen, BS, Katzenellenbogen, JA & Macchia, M 2006, 'Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands', Arkivoc, vol. 2006, no. 8, pp. 83-94.
Minutolo F, Bertini S, Martinelli A, Ortore G, Placanica G, Prota G et al. Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands. Arkivoc. 2006 Jun 24;2006(8):83-94.
Minutolo, Filippo ; Bertini, Simone ; Martinelli, Adriano ; Ortore, Gabriella ; Placanica, Giorgio ; Prota, Giovanni ; Rapposelli, Simona ; Tuccinardi, Tiziano ; Sheng, Shubin ; Carlson, Kathryn E. ; Katzenellenbogen, Benita S. ; Katzenellenbogen, John A. ; Macchia, Marco. / Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands. In: Arkivoc. 2006 ; Vol. 2006, No. 8. pp. 83-94.
@article{257a934cbfde49299cf3403cdb3483ac,
title = "Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands",
abstract = "Estrogens play a crucial role in the development and function of female reproductive tissues. They have positive effects on the maintenance of bone mineral density, on the liver, and on the cardiovascular and central nervous systems. Selective Estrogen Receptor Modulators (SERMs) are particularly attractive as therapeutic agents because they are able to block estrogen action at those sites where stimulation would be undesirable, such as the breast and uterus, but at the same time stimulate estrogen actions in other tissues where they are desired, such as the bone and liver. Most synthetic estrogen receptor ligands possess a phenolic ring, mimicking the phenolic {"}Aring{"} of the natural ligand estradiol. In an attempt to increase the structural diversity of estrogen receptor (ER) ligands, we designed and synthesized molecules containing unprecedented replacements of the prototypical phenolic {"}A-ring{"} of estrogens with an oxime and a hydroxy- (salicylaldoximes) or aminomoieties (anthranylaldoximes), forming intramolecularly H-bonded pseudocycles. These new classes of compounds showed interesting ER binding properties on both receptor subtypes (ERα and ERβ). These results proved that the six-membered ring formed by an intramolecular hydrogen bond, and containing an exocyclic oxime OH, is an effective stereoelectronic replacement of the phenolic ring of typical ER ligands.",
keywords = "Binding, Estrogen, Ligands, Nuclear receptors, Oximes",
author = "Filippo Minutolo and Simone Bertini and Adriano Martinelli and Gabriella Ortore and Giorgio Placanica and Giovanni Prota and Simona Rapposelli and Tiziano Tuccinardi and Shubin Sheng and Carlson, {Kathryn E.} and Katzenellenbogen, {Benita S.} and Katzenellenbogen, {John A.} and Marco Macchia",
year = "2006",
month = "6",
day = "24",
language = "English (US)",
volume = "2006",
pages = "83--94",
journal = "Arkivoc",
issn = "1551-7004",
publisher = "Arkat USA",
number = "8",

}

TY - JOUR

T1 - Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands

AU - Minutolo, Filippo

AU - Bertini, Simone

AU - Martinelli, Adriano

AU - Ortore, Gabriella

AU - Placanica, Giorgio

AU - Prota, Giovanni

AU - Rapposelli, Simona

AU - Tuccinardi, Tiziano

AU - Sheng, Shubin

AU - Carlson, Kathryn E.

AU - Katzenellenbogen, Benita S.

AU - Katzenellenbogen, John A.

AU - Macchia, Marco

PY - 2006/6/24

Y1 - 2006/6/24

N2 - Estrogens play a crucial role in the development and function of female reproductive tissues. They have positive effects on the maintenance of bone mineral density, on the liver, and on the cardiovascular and central nervous systems. Selective Estrogen Receptor Modulators (SERMs) are particularly attractive as therapeutic agents because they are able to block estrogen action at those sites where stimulation would be undesirable, such as the breast and uterus, but at the same time stimulate estrogen actions in other tissues where they are desired, such as the bone and liver. Most synthetic estrogen receptor ligands possess a phenolic ring, mimicking the phenolic "Aring" of the natural ligand estradiol. In an attempt to increase the structural diversity of estrogen receptor (ER) ligands, we designed and synthesized molecules containing unprecedented replacements of the prototypical phenolic "A-ring" of estrogens with an oxime and a hydroxy- (salicylaldoximes) or aminomoieties (anthranylaldoximes), forming intramolecularly H-bonded pseudocycles. These new classes of compounds showed interesting ER binding properties on both receptor subtypes (ERα and ERβ). These results proved that the six-membered ring formed by an intramolecular hydrogen bond, and containing an exocyclic oxime OH, is an effective stereoelectronic replacement of the phenolic ring of typical ER ligands.

AB - Estrogens play a crucial role in the development and function of female reproductive tissues. They have positive effects on the maintenance of bone mineral density, on the liver, and on the cardiovascular and central nervous systems. Selective Estrogen Receptor Modulators (SERMs) are particularly attractive as therapeutic agents because they are able to block estrogen action at those sites where stimulation would be undesirable, such as the breast and uterus, but at the same time stimulate estrogen actions in other tissues where they are desired, such as the bone and liver. Most synthetic estrogen receptor ligands possess a phenolic ring, mimicking the phenolic "Aring" of the natural ligand estradiol. In an attempt to increase the structural diversity of estrogen receptor (ER) ligands, we designed and synthesized molecules containing unprecedented replacements of the prototypical phenolic "A-ring" of estrogens with an oxime and a hydroxy- (salicylaldoximes) or aminomoieties (anthranylaldoximes), forming intramolecularly H-bonded pseudocycles. These new classes of compounds showed interesting ER binding properties on both receptor subtypes (ERα and ERβ). These results proved that the six-membered ring formed by an intramolecular hydrogen bond, and containing an exocyclic oxime OH, is an effective stereoelectronic replacement of the phenolic ring of typical ER ligands.

KW - Binding

KW - Estrogen

KW - Ligands

KW - Nuclear receptors

KW - Oximes

UR - http://www.scopus.com/inward/record.url?scp=33745614315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745614315&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33745614315

VL - 2006

SP - 83

EP - 94

JO - Arkivoc

JF - Arkivoc

SN - 1551-7004

IS - 8

ER -